The global mental health crisis continues escalating at an alarming pace. Depression and anxiety alone currently cost the world economy $1 trillion annually. Experts project this economic burden could swell to a staggering $6-16 trillion by 2030 as rates of mental illness proliferate across the globe.
Despite the pressing need, presently available mainstream treatments often have poor long-term outcomes and fail to deliver sufficient relief — especially for millions suffering from severe, chronic conditions like treatment-resistant depression, complex PTSD, and addiction.
However, an emerging renaissance in psychedelic-assisted therapy research shows immense promise for transforming outcomes where conventional protocols fall short.
Complex, heterogenous, and often debilitating, depression is a multifaceted condition that affects millions of people worldwide. According to current statistics, one in five Americans will experience major depressive disorder (MDD) in their lifetime, and many will not find relief from current therapeutic approaches. While there is an ever-growing list of potential causes of MDD, recent research suggests that inflammation in the body may be a contributing factor to the development and severity of depression. And the latest clinical trial data suggest that targeting and treating inflammation as the root cause may help clinicians provide more precise, personalized care to patients struggling with depression and help them achieve lasting mental and physical wellness.
A4M kicked off a bustling education season this September by hosting two industry-leading events featuring eight diverse programs, over 150 sessions, and nearly 100 highly-acclaimed expert speakers. Gathering hundreds of healthcare professionals from across the country, both conferences were remarkably successful and showcased the latest in integrative health, anti-aging, and longevity.
Between September 8-10, pediatric specialists, functional medicine experts, cardiologists, and anti-aging medicine practitioners came together in the stunning coastal town of Rancho Palos Verdes, CA – where they spent the weekend immersed in the latest education among fellow trailblazing clinicians and breathtaking scenery.